Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection

Abroad (travel likely)RecruitingPHASE3

Conditions

Aortic Dissection · Inflammation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Tuo Pan, MD

    Study Director

    The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

  • DongJin Wang, MD

    Study Chair

    The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

  • DongJin Wang, MD

    Principal Investigator

    The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School